Mochammad Arfin Fardiansyah Nasution

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Molecular Docking

Saccharomyces Cerevisiae

Gold Nanoparticles

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Rizka Fatriani, Firda Agustin Kartika Pratiwi, Annisa Annisa, Dewi Anggraini Septaningsih, Sandra Arifin Aziz, Isnatin Miladiyah, Siska Andrina Kusumastuti, Mochammad Arfin Fardiansyah Nasution, Donny Ramadhan, Wisnu Ananta Kusuma
Unveiling the anti-obesity potential of Kemuning (Murraya paniculata): A network pharmacology approach. PloS one 19 (8) (2024)
Rizka Fatriani, Firda Agustin Kartika Pratiwi, Annisa Annisa, Dewi Anggraini Septaningsih, Sandra Arifin Aziz, Isnatin Miladiyah, Siska Andrina Kusumastuti, Mochammad Arfin Fardiansyah Nasution, Donny Ramadhan, Wisnu Ananta Kusuma
Unveiling the anti-obesity potential of Kemuning (Murraya paniculata): A network pharmacology approach. PloS one 19 (8) (2024)
Aliyah, Mochammad Arfin Fardiansyah Nasution, Yulia Mariana Tesa Ayudia Putri, Jarnuzi Gunlazuardi, Tribidasari Anggraningrum Ivandini
Modification of carbon foam with 4-mercaptobenzoic acid functionalised gold nanoparticles for an application in a yeast-based microbial fuel cell. RSC advances 12 (44) (2022)
Putri Hawa Syaifie, Azza Hanif Harisna, Mochammad Arfin Fardiansyah Nasution, Adzani Gaisani Arda, Dwi Wahyu Nugroho, Muhammad Miftah Jauhar, Etik Mardliyati, Nurwenda Novan Maulana, Nurul Taufiqu Rochman, Alfian Noviyanto, Antonio Jesús Banegas-Luna, Horacio Pérez Sánchez
Computational Study of Asian Propolis Compounds as Potential Anti-Type 2 Diabetes Mellitus Agents by Using Inverse Virtual Screening with the DIA-DB Web Server, Tanimoto Similarity Analysis, and Molecular Dynamic Simulation. Molecules (Basel, Switzerland) 27 (13) (2022)
Ahmad Husein Alkaff, Mutiara Saragih, Shabrina Noor Imana, Mochammad Arfin Fardiansyah Nasution, Usman Sumo Friend Tambunan
Identification of DNA Methyltransferase-1 Inhibitor for Breast Cancer Therapy through Computational Fragment-Based Drug Design. Molecules (Basel, Switzerland) 26 (2) (2021)